Gene therapy using cDNA driven by an exogenous promoter is not suited for genetic disorders that require intrinsic expression of a transgene, such as hyperimmunoglobulin (Ig)M syndrome (HIGM), which ...
Anritsu’s Site Master cable and antenna analyzers are now available with optional vector network analyzer (VNA) and vector voltmeter (VVM) capabilities. These additions extend their use to field ...
The control of cellular and humoral responses against the transgene product is pivotal for any safe and efficacious gene therapy. The capsid serotype may have a determining role in generating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback